Findings of the Change Healthcare 2020 Revenue Cycle Denials Index indicate that since the onset of the coronavirus disease 2019 (COVID-19) pandemic, medical claim denials have risen 11% nationwide, with the most denial rates found in regions with the highest first wave of outbreaks.
New research shows Pfizer/BioNTech's vaccine is effective against the B.1.1.7. variant of coronavirus disease 2019 (COVID-19); Amazon offers to aid vaccine distribution; FDA issues drug safety labeling changes for Enhertu.
A stark 82% of assessed patients with hereditary transthyretin (ATTRv) amyloidosis exhibited at least 1 gastrointestinal symptom, warranting the need for gastroenterologists in multidisciplinary management of the disease.
Both women and men have a greater chance of 90-day hospital readmission when they are considered to be in frail condition from heart failure.
Recipients of hematopoietic stem-cell transplantation (HSCT) who develop coronavirus disease 2019 (COVID-19) may be predisposed to a greater mortality rate if they meet certain disease criteria.
Nephrologist Mary Dittrich, MD, the chief medical officer and executive vice president of U.S. Renal Care as well as cofounder and partner of Boise Kidney & Hypertension Institute, discusses how to keep patients safe while providing high-quality kidney care during the coronavirus disease 2019 pandemic.
As the nation crossed the threshold of 400,000 deaths from the pandemic, the Biden transition team said that one of his first actions will be an executive order calling on Americans to do “their patriotic duty” and wear a mask.
Lauren M. Corduck, who turned a diagnosis of ovarian cancer into a crusade to educate others with similar genetic mutations, died on December 24, 2020. She was 49.
Donald M. Berwick, MD, MPP, president emeritus and senior fellow at the Institute for Healthcare Improvement and former CMS administrator, discusses challenges in cancer care and health care awaiting the Biden transition team.
Elderly individuals have started to withdraw from Novovax’s coronavirus disease 2019 (COVID-19) vaccine trial; California reports possible allergic reactions to the Moderna COVID-19 vaccine; LGBTQ individuals increasingly report being refused health care treatment.
It will be very interesting to understand the mechanism of medication overuse headache, along with the effects antibodies have on the condition, said Rigmor Jensen, MD, professor of neurology at The University of Copenhagen and director of the Danish Headache Center.
Results of a vignette-based survey study indicate patients with diabetes require greater health benefits to adopt more intrusive remote digital monitoring (RDM), food monitoring, and real-time feedback by a health care professional.
Severe mental illnesses that precede a breast cancer diagnosis may increase the risk of both all-cause and cancer-specific mortality among women with Medicaid coverage.
As Rochelle Walensky, MD, MPH, prepares to assume the role of CDC director on January 20, the infectious disease specialist faces a myriad of challenges wrought by the ongoing coronavirus disease 2019 (COVID-19) pandemic.
Results from a prospective observational study showed aqueous transforming growth factor beta and autotaxin exhibited high diagnostic performance in detecting glaucoma subtypes and could serve as promising biomarkers for glaucoma.
In California, a novel variant of coronavirus disease 2019 (COVID-19) may be less susceptible to approved vaccines; COVID-19 vaccine trials are assessing efficacy in adolescents; HHS relaxes a regulation on prescribing addiction medication.
A study on the effects of Mediterranean diets on Parkinson disease found a strong correlation between food intake and disease onset, while also suggesting a possible link between sex and diet results.
Obstructive sleep apnea was identified as an independent risk factor for severe coronavirus disease 2019 (COVID-19) resulting in hospitalization.
Compared with triptan nonresponders, patients with migraine who report a response to at least 1 triptan have a higher likelihood of responding to treatment with erenumab, according to real-world data published in The Journal of Headache and Pain.
Results of a phase 2 trial showed that an activin type II receptor blockade, achieved via bimagrumab, led to significant loss of fat mass, gain in lean mass, and metabolic improvements among patients with type 2 diabetes (T2D) and overweight or obesity.
Swedish patients with type 2 diabetes and obesity who underwent gastric bypass surgery exhibited a reduced risk of developing new diabetic retinopathy, compared with those who did not undergo surgery.
Vaccination rates against coronavirus disease 2019 (COVID-19) are significantly lower in Black Americans compared with White Americans; spotlighting the impact of the pandemic on children with mental illness; a rapid blood test predicts which patients with COVID-19 are at highest risk of severe complications or death.
Amid recent reforms on price transparency by CMS and the Trump administration, payers' workloads will substantially increase with notable challenges that include having to maintain accurate prices and the impact of exposed negotiated rates.
Investigators found that the ratio of lymphocytes to high-density lipoprotein (HDL) performed better in predicting pulmonary function than the neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio.
The incoming Biden administration will be challenged to address flex capacity, the supply chain, and real-time data as we transition from coronavirus disease 2019 (COVID-19) response to durable recovery.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Consider social determinants of health when trying to help gay and bisexual men, stressed Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy.
A population-based study from the Netherlands showed that individuals with had at least 1 direct relative affected with chronic kidney disease (CKD), suggesting that biomarkers for CKD can aid in detecting the early stages of the disease.
A flow cytometric score developed in 2012, which uses 4 parameters to distinguish low-grade myelodysplastic syndromes (MDS) from nonclonal cytopenias, is simple and practical for screening patients with MDS, according to research published in the American Journal of Translational Research.
Tyrosine kinase inhibitor (TKI) therapy enables patients with chronic myeloid leukemia (CML) to reach life expectancies equivalent to the general population and treatment-free remission, but quality of life can deteriorate with treatment.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
